AstraZeneca (NASDAQ:AZN) said on Tuesday it will discontinue its late stage trial testing Truqap combination in patients with ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

(RTTNews) - Rezolute, Inc. (RZLT) on Wednesday announced that an independent Data Monitoring Committee or DMC has issued a positive recommendation for the ongoing Phase 3 sunRIZE study of ...

model of plan chosen (independent committee, monitor, the principle investigator) frequency of monitoring and reporting expertise of the monitoring entity level of risk involved types of data to be ...

Rezolute shares were up 29%, to $4, after the company said an independent data monitoring committee recommended the continuation of a Phase 3 Ersodetug study in patients with congenital ...

today announced that a second Independent Data Monitoring Committee (IDMC) review of data from the VIRAGE Phase 2b clinical trial in newly-diagnosed metastatic pancreatic ductal adenocarcinoma ...

Following the safety update on acute liver failure that was issued on March 18, European Union reference member country authorities requested that the independent data monitoring committee meet to ...